Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
Ramalingam, S. S.; Vansteenkiste, J.; Planchard, D.; Cho, B. C.; Gray, J. E.; Ohe, Y.; Zhou, C.; Reungwetwattana, T.; Cheng, Y.; Chewaskulyong, B.; Shah, R.; Cobo, M.; Lee, K. H.; Cheema, P.; Tiseo, M.; John, T.; Lin, M-C; Imamura, F.; Kurata, T.; Todd, A.; Hodge, R.; Saggese, M.; Rukazenkov, Y.; Soria, J-C; Boyer, Michael; Lee, Chee; Hughes, Brett; O'Byrne, Kenneth; Briggs, Peter; Milward, Michael; John, Thomas; Demedts, Ingel; Vansteenkiste, Johan; Bustin, Frederique; Barrios, Carlos Henrique; Timcheva, Constanta; Butts, Charles; Goss, Glenwood; Juergens, Rosalyn; Leighl, Natasha; Cheng, Susanna; Burkes, Ronald; Zhou, Caicun; Zhang, Helong; Shu, Yongqian; Cheng, Ying; Zhou, Qing; Li, WEI; Feng, Guosheng; He, Yong; Wang, Buhai; Gao, Hongjun; Nan, Kejun; Zhou, Xiangdong; Fan, Yun; Hunag, Jian an; Hu, YI; Liu, Yun-peng; Liu, Chunling; Zhang, Yiping; Zhu, BO; Bartek, Tomas; Monnet, Isabelle; El Kouri, Claude; Perol, Maurice; Berard, Henri; Planchard, David; Madelaine, Jeannick; von Pawel, Joachim; Grohe, Christ
-
0 Twitter
-
23 Wikipedia
-
1 News
-
204 Policy